BIOMAT Database Logo BIOMAT Database Logo

Cellular rejection in discordant xenografts when hyperacute rejection is prevented: analysis using adoptive and passive transfer. 1994

J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Department of Surgery, University of Minnesota, Minneapolis 55455.

Hyperacute rejection of discordant xenografts occurs rapidly, precluding cellular infiltration. Thus the role of cellular rejection in discordant xenografts is debated. Using adoptive transfer of sensitized splenocytes and passive transfer of sensitized serum, we evaluated the influence of cellular and humoral elements on cellular infiltration and rejection in the guinea-pig-to-rat discordant xenograft model. Guinea-pig hearts were transplanted into Lewis rats. Pretransplant, rats underwent splenectomy and plasma exchange and were started on daily cobra venom factor injections. Xenografts rejected faster after adoptive (1, 2, 2 and 2 days) or passive (1, 1, 2 and 2 days) transfer than controls (4, 4, 4 and 4 days; p < 0.05). Macrophages and neutrophils were predominant in early prerejection specimens. Over time, cellular infiltrates were dominated by mononuclear cells. Natural killer cells were present in all groups, as were interleukin 2 receptor positive cells. Our data suggest that either sensitized serum or sensitized cells are capable of initiating an accelerated rejection characterized by cellular infiltration. Despite subtle differences, the population of infiltrating cells was similar in each group. Thus, although rejection may be initiated by either cellular or humoral influences, the ultimate result is the same. We have, therefore, established a small animal model to study cellular rejection in discordant xenografts. This model will help evaluate the role of cell subsets and xenoantibodies in xenograft rejection and will help determine the precise relationship between the two when hyperacute rejection is prevented.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D004546 Elapid Venoms Venoms from snakes of the family Elapidae, including cobras, kraits, mambas, coral, tiger, and Australian snakes. The venoms contain polypeptide toxins of various kinds, cytolytic, hemolytic, and neurotoxic factors, but fewer enzymes than viper or crotalid venoms. Many of the toxins have been characterized. Cobra Venoms,Elapidae Venom,Elapidae Venoms,Naja Venoms,Cobra Venom,Elapid Venom,Hydrophid Venom,Hydrophid Venoms,King Cobra Venom,Naja Venom,Ophiophagus hannah Venom,Sea Snake Venom,Sea Snake Venoms,Venom, Cobra,Venom, Elapid,Venom, Elapidae,Venom, Hydrophid,Venom, King Cobra,Venom, Naja,Venom, Ophiophagus hannah,Venom, Sea Snake,Venoms, Cobra,Venoms, Elapid,Venoms, Elapidae,Venoms, Hydrophid,Venoms, Naja,Venoms, Sea Snake
D006082 Graft Enhancement, Immunologic The induction of prolonged survival and growth of allografts of either tumors or normal tissues which would ordinarily be rejected. It may be induced passively by introducing graft-specific antibodies from previously immunized donors, which bind to the graft's surface antigens, masking them from recognition by T-cells; or actively by prior immunization of the recipient with graft antigens which evoke specific antibodies and form antigen-antibody complexes which bind to the antigen receptor sites of the T-cells and block their cytotoxic activity. Immunologic Enhancement of Grafts,Enhancement, Immunologic Graft,Graft Enhancement,Graft Enhancement, Immunological,Immunologic Graft Enhancement,Enhancement, Graft,Enhancement, Immunological Graft,Enhancements, Graft,Enhancements, Immunologic Graft,Enhancements, Immunological Graft,Graft Enhancements,Graft Enhancements, Immunologic,Graft Enhancements, Immunological,Immunologic Graft Enhancements,Immunological Graft Enhancement,Immunological Graft Enhancements
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea

Related Publications

J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Discordant xenogeneic cellular interactions when hyperacute rejection is prevented: analysis using an ex vivo model of pig kidney perfused with human lymphocytes.
April 1996, Transplantation proceedings,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Discordant cellular xenografts revascularized in intermediate athymic hosts fail to induce a hyperacute rejection when transplanted to immunocompetent rats.
May 1994, Transplantation,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Cell-mediated hyperacute rejection. IV. Lyt markers and adoptive transfer.
May 1982, Journal of immunology (Baltimore, Md. : 1950),
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Natural IgM play a major role in hyperacute rejection of discordant heart xenografts.
April 1992, Transplantation proceedings,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
October 1992, Transplantation,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Cell-mediated hyperacute rejection. VIII. The recipient's role in adoptive transfer.
February 1985, Transplantation,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
A passive transfer model of hyperacute rat cardiac allograft rejection.
October 1979, Laboratory investigation; a journal of technical methods and pathology,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates.
July 2005, The Journal of clinical investigation,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Hyperacute renal allograft rejection in the rabbit. Passive transfer, specificity, and prevention.
November 1972, Transplantation,
J P Fryer, and J R Leventhal, and A P Dalmasso, and S Chen, and P A Simone, and J Jessurun, and L H Sun, and N L Reinsmoen, and A J Matas
Efficacy of perfluorotributylamine/pluronic F-68 stem-emulsion (FC43se) against hyperacute rejection in discordant lung xenografts.
November 1998, Transplantation proceedings,
Copied contents to your clipboard!